Gunderson Capital Management Inc. Eli Lilly & CO Transaction History

Gunderson Capital Management Inc.

$152 Million
Q1 2025

A detailed history of Gunderson Capital Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Gunderson Capital Management Inc. holds 255 shares of LLY stock, worth $192,670. This represents 0.14% of its overall portfolio holdings.

Number of Shares

255

Previous 12,313 97.93%

Holding current value

$192,670

Previous $9.51 Million 97.79%

% of portfolio

0.14%

Previous 5.17%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 09, 2025	SELL	$725.72 - $929.72 $8.75 Million - $11.2 Million	-12,058 Reduced 97.93%	255 $210,000
Q4 2024 Jan 13, 2025	SELL	$727.2 - $932.06 $7.41 Million - $9.49 Million	-10,184 Reduced 45.27%	12,313 $9.51 Million
Q3 2024 Oct 08, 2024	BUY	$772.14 - $960.02 $172,187 - $214,084	223 Added 1.0%	22,497 $19.9 Million
Q2 2024 Jul 11, 2024	BUY	$724.87 - $909.04 $1.72 Million - $2.15 Million	2,369 Added 11.9%	22,274 $20.2 Million
Q1 2024 Apr 10, 2024	BUY	$592.2 - $792.28 $738,473 - $987,973	1,247 Added 6.68%	19,905 $15.5 Million
Q4 2023 Jan 05, 2024	BUY	$525.19 - $619.13 $3.85 Million - $4.54 Million	7,327 Added 64.66%	18,658 $10.9 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $4.93 Million - $6.79 Million	11,331 New	11,331 $6.09 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $5.88 Million - $6.86 Million	18,297 New	18,297 $6.69 Million
Q2 2019 Nov 14, 2019	SELL	$110.79 - $129.32 $207,288 - $241,957	-1,871 Closed	0 $0
Q1 2019 Nov 14, 2019	BUY	$111.31 - $131.02 $890 - $1,048	8 Added 0.43%	1,871 $243,000
Q4 2018 Nov 14, 2019	BUY	$105.9 - $118.64 $197,291 - $221,026	1,863 New	1,863 $216,000

Others Institutions Holding LLY

# of Institutions

4,378

Shares Held

821M

Call Options Held

10.1M

Put Options Held

11.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $718B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gunderson Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gunderson Capital Management Inc. with notifications on news.

Account

Gunderson Capital Management Inc. Eli Lilly & CO Transaction History